User profiles for M. Pierantozzi

Mariano Pierantozzi

Universitą di Chieti Pescara
Verified email at unich.it
Cited by 1085

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease

…, P Stanzione, S Galati, D Tropepi, M Pierantozzi… - Brain, 2007 - academic.oup.com
Gait disturbances and akinesia are extremely disabling in advanced Parkinson's disease. It
has been suggested that modulation of the activity of the pedunculopontine nucleus (PPN) …

Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains

…, R Ceravolo, L Brusa, M Pierantozzi… - Journal of the …, 2010 - Elsevier
Between 2005 and 2007, six patients affected by idiopathic Parkinson's disease (IPD) were
submitted to the bilateral implantation (and subsequent deep brain stimulation — DBS) of the …

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection

C Liguori, M Pierantozzi, M Spanetta, L Sarmati… - Brain, behavior, and …, 2020 - Elsevier
Objective Coronavirus disease 2019 (COVID-19) represents a novel pneumonia leading to
severe acute respiratory syndrome (SARS). Recent studies documented that SARS-…

Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature

…, O Rascol, JF Demonet, A Stefani, M Pierantozzi… - Brain, 2010 - academic.oup.com
One objective of modern neuroimaging is to identify markers that can aid in diagnosis,
disease progression monitoring and long-term drug impact analysis. In this study, Parkinson-…

Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations

M Pierantozzi, A Pietroiusti, L Brusa, S Galati… - Neurology, 2006 - AAN Enterprises
Objective: To investigate if Helicobacter pylori (HP) eradication could make an effective and
long-lasting improvement in the pharmacokinetic and clinical response to l-dopa in patients …

[HTML][HTML] COVID 19—A qualitative review for the reorganization of human living environments

I Pierantoni, M Pierantozzi, M Sargolini - Applied Sciences, 2020 - mdpi.com
… This greatly complicates the simple reduction to two types of distances of 2 or 6 m but also
… The only exception was a crowd collection site about 1 m from the entrance of a department …

Dysbiosis of gut microbiota in a selected population of Parkinson's patients

…, R Cerroni, V Unida, A Farcomeni, M Pierantozzi… - Parkinsonism & related …, 2019 - Elsevier
Introduction In recent years the hypothesis that gut microbiota associates with Parkinson's
disease (PD) has gained importance, although it has not been possible to define a specific …

[HTML][HTML] Neurotrophins as therapeutic agents for Parkinson's disease; new chances from focused ultrasound?

A Stefani, M Pierantozzi, S Cardarelli… - Frontiers in …, 2022 - frontiersin.org
Magnetic Resonance–guided Focused Ultrasound (MRgFUS) represents an effective micro-lesioning
approach to target pharmaco-resistant tremor, mostly in patients afflicted by …

CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease

…, MG Marciani, M Pierantozzi - Journal of Neurology …, 2015 - jnnp.bmj.com
Objectives To investigate, in patients with Alzheimer's Disease (AD), the possible interplay
linking alteration of neuronal energy metabolism, as measured via cerebrospinal fluid (CSF) …

[HTML][HTML] Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease

V Pisani, A Stefani, M Pierantozzi, S Natoli… - Journal of …, 2012 - Springer
Background Alterations in blood–brain barrier permeability have been proposed to represent
a relevant factor contributing to Parkinson’s disease progression. However, few studies …